Harvard Health Letter

What you should know about: The latest blood thinners

New anticoagulants for stroke prevention in atrial fibrillation-dabigatran (Pradaxa), apixaban (Eliquis), and rivaroxaban (Xarelto)-are at least as effective as warfarin in preventing stroke and have a reduced risk of bleeding into the brain.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In